Medical Device Registration in Mexico: The COFEPRIS Guide (2026)

What Is COFEPRIS?

COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is Mexico's federal authority responsible for protecting the population from health risks posed by the use of medical products, foods, and environmental factors. For medical device manufacturers, COFEPRIS is the equivalent of the U.S. FDA. It governs device classification, facility compliance, market authorization, and post-market surveillance.

If you manufacture medical devices in Mexico or import them for sale in the Mexican market, COFEPRIS is the regulatory body that grants your authorization to operate. No registration, no market access.

COFEPRIS has been modernizing its framework over the past several years, moving toward greater alignment with international standards bodies including the International Medical Device Regulators Forum (IMDRF) and the Medical Device Single Audit Program (MDSAP). For manufacturers already operating under FDA or EU MDR frameworks, this alignment reduces the regulatory distance between your existing compliance infrastructure and what Mexico requires. For a broader look at how the regulatory environment fits into Mexico's medical device landscape, see our complete guide to medical device manufacturing in Mexico.

How Does COFEPRIS Classify Medical Devices?

COFEPRIS uses a risk-based classification system that determines the registration pathway, documentation requirements, and review timeline for each device. The system has three primary tiers:

COFEPRIS Medical Device Classification

Classification determines everything downstream. A Class I device with established technology faces a lighter documentation burden and faster review. A Class III implantable device requires a full technical dossier with clinical evidence. Getting the classification right at the outset is critical because it dictates cost, timeline, and the type of regulatory expertise you need on hand.

It is worth noting that COFEPRIS also subdivides Class II into IIa (lower-moderate risk) and IIb (higher-moderate risk) categories for certain regulatory purposes. For most manufacturers coming from an FDA-regulated environment, the three-tier framework maps closely to the FDA's own Class I/II/III system, which simplifies the classification analysis.

What Are the COFEPRIS Registration Pathways?

There are two primary routes to COFEPRIS registration, and the one you use depends largely on whether your device already holds clearance from a recognized international authority.

Standard Registration requires a full technical dossier submitted directly to COFEPRIS. This includes detailed device descriptions, design specifications, clinical evidence supporting safety and efficacy, quality system documentation, and Spanish-language labeling. Review timelines under the standard route range from 30 days for low-risk devices to 6 months or more for Class III products.

Abbreviated Regulatory Pathway (Equivalency Route) is the more significant development. Effective September 1, 2025, COFEPRIS launched a fast-track registration route for devices that already hold approval from an IMDRF or MDSAP-recognized authority. That includes the FDA, Health Canada, the European Medicines Agency (under EU MDR), Swissmedic, Australia's TGA, and several others. Under this pathway, manufacturers submit a summary dossier rather than the full technical package, and COFEPRIS targets a 30-day review window.

The practical significance: for most U.S.-based medical device companies that already hold FDA clearance and ISO 13485 certification, the path to COFEPRIS registration has shortened from months to weeks. That said, actual review times can vary depending on COFEPRIS workload and dossier completeness, so manufacturers should plan with some buffer built in.

What Documentation Does COFEPRIS Require?

Regardless of pathway, COFEPRIS requires several core elements:

Mexico Registration Holder (MRH). Foreign manufacturers cannot register directly with COFEPRIS. You must appoint a local legal entity based in Mexico to serve as your authorized representative. The MRH manages all regulatory interactions with COFEPRIS on the manufacturer's behalf, including application submissions, renewals, and post-market incident reporting through Mexico's Technovigilance system.

Technical dossier. The standard route requires detailed device descriptions, intended use statements, design drawings, biocompatibility data (where applicable), and clinical evidence. The abbreviated route requires a summary dossier referencing the existing foreign approval.

Quality system evidence. ISO 13485 certification is not legally mandatory in Mexico, but COFEPRIS expects manufacturers to demonstrate a robust quality management system. In practice, an ISO 13485 certificate, CE Mark, MDSAP audit report, or Certificate of Good Manufacturing Practices is the standard expectation. ISO 13485 also satisfies Mexico's NOM-241-SSA1-2012 Good Manufacturing Practice standard through an established equivalency, which means companies already operating under ISO frameworks can achieve GMP compliance without building a separate Mexican quality system.

Spanish-language labeling. Devices sold in the Mexican domestic market must include labeling in Spanish per NOM-137-SSA1-2008, including generic name, country of origin, registration number, expiration date, and lot/serial number. Devices manufactured exclusively for export follow the importing country's labeling standards.

Registration validity. COFEPRIS registrations are valid for five years. As of January 2026, subsequent renewals can be granted for periods of up to ten years, reducing the ongoing compliance overhead for established products.

What Changed in 2025–2026?

The COFEPRIS regulatory environment has shifted meaningfully over the past 18 months. Three changes matter most for manufacturers:

September 2025: Abbreviated Pathway launch. This is the headline reform. It created the fast-track equivalency route described above, leveraging IMDRF/MDSAP approvals to compress registration timelines. For companies already holding FDA clearance, this removed one of the historical friction points of manufacturing in Mexico. Source: Pure Global Compliance.

March 2025: Simplification measures. COFEPRIS published new provisions in the Diario Oficial de la Federación that reduced bureaucratic steps and updated risk classification protocols. Standard review timelines for certain lower-risk categories compressed from 30 to 20 business days.

January 2026: Extended renewals and clinical research reform. Subsequent device registrations can now be renewed for up to 10 years, and updated requirements for Bioethics Committees took effect for clinical trial authorizations.

The direction is clear: COFEPRIS is moving toward greater international alignment and faster review timelines. For manufacturers evaluating Mexico, the regulatory environment is more accessible today than at any point in the past decade.

How Does COFEPRIS Registration Fit Your Mexico Strategy?

COFEPRIS registration does not happen in isolation. It is one element of a broader operational launch that includes site selection, IMMEX enrollment for duty-free import of materials and equipment, workforce recruitment, facility buildout, and supply chain setup. The companies that navigate this process efficiently are typically the ones that plan the regulatory and operational workstreams in parallel rather than sequentially.

This is where the choice of operating model matters. Under a Manufacturing Campus model, much of the operational infrastructure is already in place. IMMEX permits are active, labor law compliance is managed, and the administrative platform is established. That frees your team to focus on COFEPRIS registration, production line validation, and quality system deployment rather than spending the first 6–12 months building corporate infrastructure from scratch.

Tetakawi has supported hundreds of manufacturers in Mexico over 40+ years of operations, including medical device companies producing Class II and Class III devices in Sonora. Our Manufacturing Campus model provides the operational foundation while manufacturers retain full control of production, quality, and intellectual property. The regulatory process is one piece of the puzzle. Having an experienced operational partner alongside you reduces the complexity of everything else.

Talk to our team about how the Manufacturing Campus model supports your Mexico manufacturing strategy, from site selection to regulatory navigation.

Frequently Asked Questions

Do I need a local representative to register medical devices with COFEPRIS?

Yes. Foreign manufacturers must appoint a Mexico Registration Holder (MRH), a legal entity based in Mexico that serves as your authorized representative for all COFEPRIS regulatory interactions. The MRH manages application submissions, renewals, and post-market incident reporting on the manufacturer's behalf.

How long does COFEPRIS medical device registration take?

Timelines vary by device classification and registration pathway. Under the standard route, Class I devices take approximately 20–30 days, Class II devices take 30–60 days, and Class III devices can take 60–180 days. The Abbreviated Regulatory Pathway, available since September 2025 for devices with existing FDA or IMDRF-recognized approvals, targets a 30-day review window across all classes. Actual timelines may vary based on dossier completeness and COFEPRIS workload.

Does COFEPRIS accept FDA approval for medical devices?

Yes. Since September 2025, COFEPRIS offers an Abbreviated Regulatory Pathway that leverages existing approvals from IMDRF and MDSAP-recognized authorities, including the FDA, Health Canada, the European Medicines Agency, Swissmedic, and Australia's TGA. Manufacturers submit a summary dossier rather than a full technical package, and the review targets 30 days.

Is ISO 13485 required for COFEPRIS registration?

ISO 13485 is not legally mandatory in Mexico, but it is the practical standard. COFEPRIS expects manufacturers to provide evidence of a robust quality management system, and an ISO 13485 certificate is the most widely accepted form of that evidence. ISO 13485 also satisfies Mexico's NOM-241 Good Manufacturing Practice standard through an equivalency pathway, so manufacturers with existing certification do not need to build a parallel Mexican quality system.

This content is for informational purposes only and does not constitute legal or regulatory advice. Manufacturers should consult qualified regulatory affairs professionals for guidance specific to their products and classification.